Trial shows personalised medicine benefit in cancer patients
A clinical trial involving patients with advanced cancers is the first of its kind to show the benefit precision medicine can have on delaying tumour recurrence.
Read More
Tag: personalised medicines
- Transgene completes randomisation in phase 2 trial of tg4050
- Bayer wins MHRA approval for Kerendia in heart failure
- Oxford BioTherapeutics signs collaboration with Bristol Myers Squibb
- Kainova expands DT 7012 trial into Europe
- Amgen reports positive phase 3 results for subcutaneous TEPEZZA in thyroid eye disease
